Twitter Facebook LinkedIn YouTube

BioNeutra Global Corporation (CSE: BGA) Announces non-brokered placement

Video Platform Video Management Video Solutions Video Player

The offering of up to 2.5 million shares is priced at $0.40 per share for gross proceeds of up to $1 million. BioNeutra is in the business of research and development, production and commercialization of ingredients for nutraceutical, functional and mainstream foods and beverages, with a focus on oligosaccharides.

Additional Information:

Company: BioNeutra Global Corporation
Website: http://www.bioneutra.ca/
Stock Symbol: CSE: BGA
Date Published: May 21, 2015
Transcript: Available

Video Transcript:

I’m Amanda Rose Schellenberg for Investmentpitch Media

BioNeutra Global Corporation, symbol BGA on the Canadian Securities Exchange, announced a non-brokered private placement.

The offering of up to 2.5 million shares is priced at $0.40 per share for gross proceeds of up to $1 million.

BioNeutra is in the business of research and development, production and commercialization of ingredients for nutraceutical, functional and mainstream foods and beverages, with a focus on oligosaccharides.

The company’s lead product, VitaFiber™, an advanced functional and health food ingredient scientifically made from agriculture cereal crops including corn, wheat, barley, potato, or tapioca, is generally regarded as safe by the U.S. Food & Drug Administration, and is European Food Safety Authority and Health Canada approved.

VitaFiber™ is naturally sweet and lower in calories than regular sugar and is a natural source of dietary fiber as it provides low calorie soluble prebiotic fiber for human digestive health.

VitaFiber™ is also non-GMO, vegan-friendly, gluten-free, Kosher and Halal certified and available as certified organic.

Proceeds of the offering will be used for general working capital.

The shares are trading at $0.50, and with 40 million shares outstanding, the company is capitalized at $20 million.

For more information on the company, please visit their website www.bioneutra.ca or contact Bill Smith, Chairman, at 780-466-1481 or email bsmith@bioneutra.ca..

I’m Amanda Rose Schellenberg for Investmentpitch Media
For more video news, and to view our disclaimer, please visit our website at www.investmentpitch.com and to receive our latest videos, please sign up for our RSS feed.
This video is for information purposes only and it not a recommendation to buy or sell any securities.